Alinsub, Jan Rylle .
HRN: 26-18-26 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/11/2024
CEFUROXIME 250MG/5ML, 50ML SUSPENSION (BOT)
11/11/2024
11/18/2024
PO
6.5ml
BID
PCAP
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes